Open Access 01.12.2022 | Hypothesis
Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma
Erschienen in: Cancer Cell International | Ausgabe 1/2022
Open Access 01.12.2022 | Hypothesis
Erschienen in: Cancer Cell International | Ausgabe 1/2022